Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA-HCl Topical Powder PDT for Moderate to Severe Acne (Phase II)
CTR20212082Phase 2Completed
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in acne vulgaris, sponsored by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Started Dec 2021; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20212082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212082.